Synthesis and evaluation of novel pyrrolidinone-based farnesyltransferase inhibitors.

被引：0
|
作者：
Gallicchio, SN
Beese, LS
Bell, IM
Beshore, DC
Buser-Doepner, C
Gibbs, JB
Graham, SL
Hartman, GD
Heimbrook, DC
Kassahun, K
Koblan, KS
Kohl, NE
Lobell, RB
Rodrigues, DA
Taylor, JS
Williams, TM
机构：
[1] Merck Res Labs, Dept Med Chem, W Point, PA 19486 USA
[2] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA
[3] Merck Res Labs, Canc Res, W Point, PA 19486 USA
[4] Merck Res Labs, Dept Drug Metab, W Point, PA 19486 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2001年 / 221卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
155-MEDI
引用
收藏
页码：U28 / U28
页数：1
相关论文
共 50 条
  • [1] Thiazolidinediones as novel farnesyltransferase inhibitors.
    Ayral-Kaloustian, S
    Birnberg, GH
    Cheung, K
    Epstein, JW
    MacEwan, G
    Salaski, E
    Hollander, I
    Kim, SC
    Chen, J
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U653 - U653
  • [2] Design and synthesis of pyridone farnesyltransferase inhibitors.
    Hasvold, LA
    Wang, WB
    Rockway, TW
    Gwaltney, SL
    Nelson, LTJ
    Mantei, R
    Fakhoury, S
    Sullivan, G
    Wang, L
    Lin, NH
    Li, Q
    Cohen, J
    Gu, WZ
    Zhang, HY
    Marsh, K
    Bauch, J
    Gintant, G
    McDermott, J
    Salmen, H
    Rosenberg, S
    Sham, H
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U28 - U28
  • [3] Protein farnesyltransferase inhibitors.
    Graham, SL
    Anthony, NJ
    Conner, MW
    deSolms, SJ
    Gibbs, JB
    Hartman, GD
    Koblan, KS
    Kohl, NE
    Oliff, A
    Omer, CA
    Williams, TM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 215 : U889 - U889
  • [4] Evolving therapies: farnesyltransferase inhibitors.
    Purcell W.T.
    Donehower R.C.
    Current Oncology Reports, 2002, 4 (1) : 29 - 36
  • [5] Synthesis and evaluation of novel heterocyclic MMP inhibitors.
    Cook, GR
    Xu, W
    Manivannan, E
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U958 - U958
  • [6] Synthesis and biological evaluation of novel calcium influx inhibitors.
    McCalmont, WF
    Patterson, JR
    Macdonald, TL
    Haverstick, DM
    Gray, LS
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U188 - U188
  • [7] Design, synthesis, and biological evaluation of novel angiogenesis inhibitors.
    Bowen, JP
    Furness, S
    Robinson, TP
    Ehlers, T
    Arbiser, JL
    Goldsmith, D
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 223 : U465 - U465
  • [8] Computational and combinatorial chemistry-based approach to farnesyltransferase inhibitors.
    Park, JG
    Kollmeyer, TM
    Xu, K
    Prendergast, FG
    Pang, YP
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U27 - U27
  • [9] A Novel Proteomic Approach to Define Leukemia Cell Resistance to Farnesyltransferase Inhibitors.
    Onono, Fredrick O.
    Morgan, Michael A.
    Spielmann, H. Peter
    Andres, Douglas A.
    Scherr, Michaela
    Venturini, Letizia
    Dallman, Iris
    Ganser, Arnold
    Reuter, Christoph W. M.
    BLOOD, 2009, 114 (22) : 1448 - 1448
  • [10] Design, synthesis and structure-activity relationships of tetrahydroquinoline farnesyltransferase inhibitors.
    Lombardo, LJ
    Bhide, R
    Camuso, A
    Clark, J
    Fager, K
    Gullo-Brown, J
    Hunt, JT
    Inigo, I
    Kan, D
    Lee, F
    Manne, V
    McGlinchey, K
    Qian, LG
    Ricca, C
    Rovnyak, G
    Sheng, C
    Traeger, S
    Williams, D
    Wu, L
    Yang, J
    Zhao, YF
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U174 - U175
12345